Cargando…

Impact of tranexamic acid use on blood loss and transfusion rates following femoral varus derotational osteotomy in children with cerebral palsy

PURPOSE: Previous studies have established the safety and efficacy of tranexamic acid (TXA) in reducing blood loss after total joint arthroplasty and spinal fusion surgery; however, literature regarding the effectiveness of intraoperative TXA in children with cerebral palsy (CP) is limited. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Nazareth, A., Shymon, S. J., Andras, L., Goldstein, R. Y., Kay, R. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Editorial Society of Bone & Joint Surgery 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442504/
https://www.ncbi.nlm.nih.gov/pubmed/30996744
http://dx.doi.org/10.1302/1863-2548.13.180143
_version_ 1783407720832958464
author Nazareth, A.
Shymon, S. J.
Andras, L.
Goldstein, R. Y.
Kay, R. M.
author_facet Nazareth, A.
Shymon, S. J.
Andras, L.
Goldstein, R. Y.
Kay, R. M.
author_sort Nazareth, A.
collection PubMed
description PURPOSE: Previous studies have established the safety and efficacy of tranexamic acid (TXA) in reducing blood loss after total joint arthroplasty and spinal fusion surgery; however, literature regarding the effectiveness of intraoperative TXA in children with cerebral palsy (CP) is limited. The aim of this study was to investigate the safety and efficacy of intraoperative TXA in reducing blood loss and transfusion requirements for children with CP undergoing a proximal femoral varus derotational osteotomy (VDRO). METHODS: This is a retrospective review of 258 children with CP who underwent VDRO performed at the author’s institution between 2004 and 2017. In all, 36 subjects underwent VDRO surgery with administration of intravenous TXA and 222 subjects underwent VDRO without administration of TXA. Outcome measures including blood loss, transfusion requirements and venous thromboembolic events were compared between groups using t-tests and chi-squared tests. RESULTS: No significant differences were seen in the rates of transfusion between groups for the entire hospitalization (TXA group: 11.1% versus No TXA group: 19.8%), intraoperatively (TXA: 2.8% versus No TXA: 9.0%) or postoperatively (TXA: 8.3% versus No TXA: 14.4%). Intraoperative estimated blood loss (TXA: 144.4 mL versus No TXA: 159.0 mL) and percentage blood loss (TXA: 8.9% versus No TXA: 9.2%) were similar between groups. No major thromboembolic complications events occurred in either group. CONCLUSION: The use of TXA was not associated with thromboembolic complications in this series of children with CP undergoing VDRO surgery. Though there was a trend toward lower rates of intraoperative and postoperative blood transfusion with TXA use in these patients, the differences were not significant, possibly due to low estimated blood loss in both groups and sample size. LEVEL OF EVIDENCE: III- retrospective comparative study
format Online
Article
Text
id pubmed-6442504
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The British Editorial Society of Bone & Joint Surgery
record_format MEDLINE/PubMed
spelling pubmed-64425042019-04-17 Impact of tranexamic acid use on blood loss and transfusion rates following femoral varus derotational osteotomy in children with cerebral palsy Nazareth, A. Shymon, S. J. Andras, L. Goldstein, R. Y. Kay, R. M. J Child Orthop Original Clinical Article PURPOSE: Previous studies have established the safety and efficacy of tranexamic acid (TXA) in reducing blood loss after total joint arthroplasty and spinal fusion surgery; however, literature regarding the effectiveness of intraoperative TXA in children with cerebral palsy (CP) is limited. The aim of this study was to investigate the safety and efficacy of intraoperative TXA in reducing blood loss and transfusion requirements for children with CP undergoing a proximal femoral varus derotational osteotomy (VDRO). METHODS: This is a retrospective review of 258 children with CP who underwent VDRO performed at the author’s institution between 2004 and 2017. In all, 36 subjects underwent VDRO surgery with administration of intravenous TXA and 222 subjects underwent VDRO without administration of TXA. Outcome measures including blood loss, transfusion requirements and venous thromboembolic events were compared between groups using t-tests and chi-squared tests. RESULTS: No significant differences were seen in the rates of transfusion between groups for the entire hospitalization (TXA group: 11.1% versus No TXA group: 19.8%), intraoperatively (TXA: 2.8% versus No TXA: 9.0%) or postoperatively (TXA: 8.3% versus No TXA: 14.4%). Intraoperative estimated blood loss (TXA: 144.4 mL versus No TXA: 159.0 mL) and percentage blood loss (TXA: 8.9% versus No TXA: 9.2%) were similar between groups. No major thromboembolic complications events occurred in either group. CONCLUSION: The use of TXA was not associated with thromboembolic complications in this series of children with CP undergoing VDRO surgery. Though there was a trend toward lower rates of intraoperative and postoperative blood transfusion with TXA use in these patients, the differences were not significant, possibly due to low estimated blood loss in both groups and sample size. LEVEL OF EVIDENCE: III- retrospective comparative study The British Editorial Society of Bone & Joint Surgery 2019-04-01 /pmc/articles/PMC6442504/ /pubmed/30996744 http://dx.doi.org/10.1302/1863-2548.13.180143 Text en Copyright © 2019, The author(s) http://creativecommons.org/licenses/by-nc/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International (CC BY-NC 4.0) licence (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed.
spellingShingle Original Clinical Article
Nazareth, A.
Shymon, S. J.
Andras, L.
Goldstein, R. Y.
Kay, R. M.
Impact of tranexamic acid use on blood loss and transfusion rates following femoral varus derotational osteotomy in children with cerebral palsy
title Impact of tranexamic acid use on blood loss and transfusion rates following femoral varus derotational osteotomy in children with cerebral palsy
title_full Impact of tranexamic acid use on blood loss and transfusion rates following femoral varus derotational osteotomy in children with cerebral palsy
title_fullStr Impact of tranexamic acid use on blood loss and transfusion rates following femoral varus derotational osteotomy in children with cerebral palsy
title_full_unstemmed Impact of tranexamic acid use on blood loss and transfusion rates following femoral varus derotational osteotomy in children with cerebral palsy
title_short Impact of tranexamic acid use on blood loss and transfusion rates following femoral varus derotational osteotomy in children with cerebral palsy
title_sort impact of tranexamic acid use on blood loss and transfusion rates following femoral varus derotational osteotomy in children with cerebral palsy
topic Original Clinical Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442504/
https://www.ncbi.nlm.nih.gov/pubmed/30996744
http://dx.doi.org/10.1302/1863-2548.13.180143
work_keys_str_mv AT nazaretha impactoftranexamicaciduseonbloodlossandtransfusionratesfollowingfemoralvarusderotationalosteotomyinchildrenwithcerebralpalsy
AT shymonsj impactoftranexamicaciduseonbloodlossandtransfusionratesfollowingfemoralvarusderotationalosteotomyinchildrenwithcerebralpalsy
AT andrasl impactoftranexamicaciduseonbloodlossandtransfusionratesfollowingfemoralvarusderotationalosteotomyinchildrenwithcerebralpalsy
AT goldsteinry impactoftranexamicaciduseonbloodlossandtransfusionratesfollowingfemoralvarusderotationalosteotomyinchildrenwithcerebralpalsy
AT kayrm impactoftranexamicaciduseonbloodlossandtransfusionratesfollowingfemoralvarusderotationalosteotomyinchildrenwithcerebralpalsy